An antibody or antigen-binding fragment thereof targeting integrin a2b1 and use thereof

Abstract

The invention also relates to immunoconjugates constructed based on the binding molecule, such as antibody-drug conjugates (ADCs). In addition, the invention encompasses nucleic acids encoding such antibodies or antibody fragments, host cells comprising said antibodies, antibody fragments, or nucleic acids, pharmaceutical compositions comprising the antibodies, antibody fragments, or immunoconjugates, as well as therapeutic and diagnostic methods or uses applying the antibodies, antibody fragments, or immunoconjugates.

Images